Hydrogen Hybrid Technologies, Inc.
Hydrogen Hybrid Technologies, Inc.
Your view on HYHY
Overview
What the company does, where it operates, and who runs it.
About Hydrogen Hybrid Technologies, Inc.
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Frank Carino
- Headquarters
- 1845 Sandstone Manor, Pickering, ON, CA
- Industry
- Medical - Pharmaceuticals
- Sector
- Healthcare
- CEO
- Frank Carino
- Headquarters
- 1845 Sandstone Manor, Pickering, ON, CA
Hydrogen Hybrid Technologies, Inc. manufactures, sales and distributes on-board hydrogen generating and injections systems for the original equipment manufacturers in car and light truck markets. Its on-board hydrogen generating system improves fuel consumption and reduces pollution through the enhancement of the internal combustion process.
This technology consists of an on-board system, which generates hydrogen and oxygen by splitting distilled water. In addition, the company holds rights to distribute the product to other markets, including the heavy goods vehicle market. Hydrogen Hybrid Technologies, Inc. is based in Pickering, Canada.
Media
Infographics, videos, and posts covering the company.
Stock Data
Price chart, volume, and trading data.
Fair Value
What FRC thinks it is worth vs. the current price.
FRC's fair value estimate for Hydrogen Hybrid Technologies, Inc., and the rating behind it. HYHY last traded at $0.0001; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
Valuation, profitability, liquidity and leverage ratios for Hydrogen Hybrid Technologies, Inc.. Starting points for Hydrogen Hybrid Technologies, Inc.: EPS -$0.03, beta -8.04 — an Medical - Pharmaceuticals name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
Dividend history, yield and payout sustainability for Hydrogen Hybrid Technologies, Inc.. Hydrogen Hybrid Technologies, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
Reported vs. expected earnings history for Hydrogen Hybrid Technologies, Inc.. Trailing twelve-month EPS for Hydrogen Hybrid Technologies, Inc. stands at -$0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
Income statement, balance sheet and cash flow history for Hydrogen Hybrid Technologies, Inc.. Hydrogen Hybrid Technologies, Inc. has reported as a listed company since 2006. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
Hydrogen Hybrid Technologies, Inc. valued side by side against its closest peers. Hydrogen Hybrid Technologies, Inc. is measured against Medical - Pharmaceuticals peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.
Institutional Ownership
PremiumWhich funds and firms own the stock.
Which institutions hold Hydrogen Hybrid Technologies, Inc., and how their positions are changing. At a $9,375 market value, institutional positions materially move Hydrogen Hybrid Technologies, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.
Insider Trading
PremiumRecent buying and selling by company executives.
Buying and selling by Hydrogen Hybrid Technologies, Inc. executives and directors. Shares of Hydrogen Hybrid Technologies, Inc. have traded between $0.0001 and $0.0002 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.
Senate Trading
PremiumU.S. Senator disclosures filed under the STOCK Act.
U.S. Senate disclosures naming Hydrogen Hybrid Technologies, Inc.. Hydrogen Hybrid Technologies, Inc. is a $9,375 Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.
House Trading
PremiumU.S. Representative disclosures filed under the STOCK Act.
U.S. House of Representatives disclosures naming Hydrogen Hybrid Technologies, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.
News
Latest headlines and market coverage.
Latest headlines and company announcements for Hydrogen Hybrid Technologies, Inc.. Coverage tracks Hydrogen Hybrid Technologies, Inc. within Medical - Pharmaceuticals (Healthcare). Press releases and market coverage, newest first.